FINANCIAL REPORTS 

2022/2023

As a result of Bluefish Pharmaceuticals AB being a subsidiary consolidated by Färna Invest AB, Bluefish has, in accordance with current legislation, adapted the financial year to Färna Group in 2022.  The financial year covers the period 1 May to 30 April. The financial year of the conversion year has been extended and covers the period from 1 January 2022 to 30 April 2023.

In consequence, from June 2022 interim reports are therefore prepared and made available only to shareholders who so request.

2021

2020

2019